Compile Data Set for Download or QSAR
Report error Found 30 Enz. Inhib. hit(s) with all data for entry = 10979
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Dana-Farber Cancer Institute

WIPO
LigandPNGBDBM581914(WO2023003973, Compound 121)
Affinity DataIC50: 20nMAssay Description:Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2023003973

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Dana-Farber Cancer Institute

WIPO
LigandPNGBDBM581942(WO2023003973, Compound Table2.22)
Affinity DataIC50: 20nMAssay Description:Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2023003973

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Dana-Farber Cancer Institute

WIPO
LigandPNGBDBM581941(WO2023003973, Compound Table2.21)
Affinity DataIC50: 20nMAssay Description:Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2023003973

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Dana-Farber Cancer Institute

WIPO
LigandPNGBDBM581926(WO2023003973, Compound Table2.19)
Affinity DataIC50: 20nMAssay Description:Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2023003973

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Dana-Farber Cancer Institute

WIPO
LigandPNGBDBM581925(WO2023003973, Compound Table2.18)
Affinity DataIC50: 20nMAssay Description:Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2023003973

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Dana-Farber Cancer Institute

WIPO
LigandPNGBDBM581924(WO2023003973, Compound Table2.17)
Affinity DataIC50: 20nMAssay Description:Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2023003973

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Dana-Farber Cancer Institute

WIPO
LigandPNGBDBM581923(WO2023003973, Compound Table2.16)
Affinity DataIC50: 20nMAssay Description:Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2023003973

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Dana-Farber Cancer Institute

WIPO
LigandPNGBDBM581922(WO2023003973, Compound Table2.14)
Affinity DataIC50: 20nMAssay Description:Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2023003973

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Dana-Farber Cancer Institute

WIPO
LigandPNGBDBM581921(WO2023003973, Compound Table2.13)
Affinity DataIC50: 20nMAssay Description:Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2023003973

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Dana-Farber Cancer Institute

WIPO
LigandPNGBDBM581920(WO2023003973, Compound Table2.11)
Affinity DataIC50: 20nMAssay Description:Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2023003973

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Dana-Farber Cancer Institute

WIPO
LigandPNGBDBM581919(WO2023003973, Compound Table2.4)
Affinity DataIC50: 20nMAssay Description:Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2023003973

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Dana-Farber Cancer Institute

WIPO
LigandPNGBDBM581918(WO2023003973, Compound Table2.3)
Affinity DataIC50: 20nMAssay Description:Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2023003973

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Dana-Farber Cancer Institute

WIPO
LigandPNGBDBM581917(WO2023003973, Compound 136)
Affinity DataIC50: 20nMAssay Description:Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2023003973

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Dana-Farber Cancer Institute

WIPO
LigandPNGBDBM581916(WO2023003973, Compound 130)
Affinity DataIC50: 20nMAssay Description:Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2023003973

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Dana-Farber Cancer Institute

WIPO
LigandPNGBDBM581915(WO2023003973, Compound 123)
Affinity DataIC50: 20nMAssay Description:Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2023003973

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Dana-Farber Cancer Institute

WIPO
LigandPNGBDBM581898(WO2023003973, Compound 7)
Affinity DataIC50: 20nMAssay Description:Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2023003973

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Dana-Farber Cancer Institute

WIPO
LigandPNGBDBM581913(WO2023003973, Compound 120)
Affinity DataIC50: 20nMAssay Description:Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2023003973

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Dana-Farber Cancer Institute

WIPO
LigandPNGBDBM581912(WO2023003973, Compound 119)
Affinity DataIC50: 20nMAssay Description:Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2023003973

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Dana-Farber Cancer Institute

WIPO
LigandPNGBDBM581911(WO2023003973, Compound 116)
Affinity DataIC50: 20nMAssay Description:Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2023003973

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Dana-Farber Cancer Institute

WIPO
LigandPNGBDBM581910(WO2023003973, Compound 114)
Affinity DataIC50: 20nMAssay Description:Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2023003973

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Dana-Farber Cancer Institute

WIPO
LigandPNGBDBM581909(WO2023003973, Compound 109)
Affinity DataIC50: 20nMAssay Description:Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2023003973

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Dana-Farber Cancer Institute

WIPO
LigandPNGBDBM581908(WO2023003973, Compound 108)
Affinity DataIC50: 20nMAssay Description:Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2023003973

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Dana-Farber Cancer Institute

WIPO
LigandPNGBDBM581907(WO2023003973, Compound 106)
Affinity DataIC50: 20nMAssay Description:Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2023003973

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Dana-Farber Cancer Institute

WIPO
LigandPNGBDBM581906(WO2023003973, Compound 93)
Affinity DataIC50: 20nMAssay Description:Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2023003973

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Dana-Farber Cancer Institute

WIPO
LigandPNGBDBM581905(WO2023003973, Compound 87)
Affinity DataIC50: 20nMAssay Description:Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2023003973

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Dana-Farber Cancer Institute

WIPO
LigandPNGBDBM581903(WO2023003973, Compound 78)
Affinity DataIC50: 20nMAssay Description:Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2023003973

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Dana-Farber Cancer Institute

WIPO
LigandPNGBDBM581902(WO2023003973, Compound 75)
Affinity DataIC50: 20nMAssay Description:Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2023003973

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Dana-Farber Cancer Institute

WIPO
LigandPNGBDBM581901(WO2023003973, Compound 49)
Affinity DataIC50: 20nMAssay Description:Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2023003973

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Dana-Farber Cancer Institute

WIPO
LigandPNGBDBM581900(WO2023003973, Compound 41)
Affinity DataIC50: 20nMAssay Description:Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2023003973

TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
Dana-Farber Cancer Institute

WIPO
LigandPNGBDBM581899(WO2023003973, Compound 33)
Affinity DataIC50: 20nMAssay Description:Dilute the compounds to 400 x of the final desired highest inhibitor concentration in reaction by 100% DMSO. For all compounds, transfer the compound...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2023003973